AN FUTURISTIC ANALYSIS OF FOCAL LIVER HEPATIC TUMORS USING FUSION OPTIMIZATION TECHNIQUES

<p>The early and<a href="https://ijetrm.com/issues/files/Aug-2025-20-1755685108-AUG23.pdf" target="_blank" rel="noopener"> precise detection </a>of focal liver cancer remains a critical challenge in medical imaging, where<br>traditional diagnostic methods often suffer from limitations in sensitivity, specificity, and robustness. With the<br>rapid advancement of artificial intelligence, fusion-based optimization techniques integrated with MRI scans have<br>emerged as a transformative pathway to enhance diagnostic accuracy. This study presents a futuristic analysis of<br>focal liver cancer detection by leveraging a hybrid fusion optimization framework that synergizes deep learning<br>architectures with evolutionary algorithms. The proposed approach integrates convolutional neural networks<br>(CNNs) for feature extraction, attention-driven U-Net models for tumor segmentation, and metaheuristic<br>optimization for parameter fine-tuning. MRI scans are employed due to their superior contrast resolution and noninvasive capability to delineate soft tissue abnormalities. The fusion optimization model enhances multi-level<br>feature representation, reduces noise, and improves lesion boundary identification, addressing the issue of<br>heterogeneity in tumor appearance. Additionally, ensemble strategies are incorporated to minimize false positives<br>and improve generalization across diverse patient datasets. Performance is evaluated using precision, recall, F1-<br>score, Dice coefficient, and area under the curve (AUC), demonstrating significant improvement over<br>conventional single-model approaches. Beyond detection, the framework holds potential for risk stratification and<br>treatment planning, making it an invaluable tool for personalized healthcare. This futuristic paradigm underscores<br>the convergence of imaging, artificial intelligence, and optimization as a robust methodology to redefine focal<br>liver cancer diagnostics. By bridging computational intelligence with clinical imaging, the proposed strategy sets<br>the foundation for next-generation precision oncology</p>